They are Dr Ike Ahmed of the Prism Eye Institute, who will become chairman and Dr Rosa Braga-Mele, who comes from the University of Toronto.
This board will help Aequus in determining whether a product can improve patient outcomes, integrate into a clinician's workflow, and navigate the Canadian reimbursement and commercial landscape.
"The formation of our advisory board is another step in our continued commitment to the ophthalmic space in Canada," said Doug Janzen, chairman and CEO of Aequus Pharmaceuticals.
Dr Ahmed has become world renowned for his skills and ground-breaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications
Dr Rosa Braga-Mele is a cataract specialist and educator who speaks frequently at both the national and international level on advanced surgical techniques, innovations in phacoemulsification surgery, complicated cataract cases, and IOL development.